sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2140 |
4. Check minimum number of eventsNone |
2140 |
5. Include endpointsNone |
2140 |
6. Filter based on genotype QC (FinnGen only) |
2068 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Cholangitis (primary sclerosing, PSC) based on the number of shared cases.
Similar with more cases:
- Disorders of gallbladder, biliary tract and pancreas
- Gastrointestinal diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 17623 | 8929 | 8513 |
Only index persons | 14119 | 7308 | 6811 |
Unadjusted period prevalence (%) | |||
Whole population | 0.25 | 0.26 | 0.24 |
Only index persons | 0.26 | 0.27 | 0.26 |
Median age at first event (years) | |||
Whole population | 69.88 | 71.11 | 68.55 |
Only index persons | 69.40 | 70.72 | 67.98 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2068 | 983 | 1085 |
Unadjusted period prevalence (%) | 0.47 | 0.39 | 0.54 |
Median age at first event (years) | 62.63 | 58.77 | 66.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint K11_CHOLANGI and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
K11_CHOLANGI | 2.458 [2.14, 2.83] | < 0.001 |
Birth year | 0.992 [0.98, 1.0] | 0.054 |
During the follow-up period (1.1.1998 — 31.12.2019), 2720 out of 6016 females with K11_CHOLANGI died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
K11_CHOLANGI | 2.52 [2.17, 2.93] | < 0.001 |
Birth year | 0.987 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 2735 out of 5897 males with K11_CHOLANGI died.
Mortality risk
Mortality risk for people of age
years, who have K11_CHOLANGI.N-year risk | Females | Males |
---|---|---|
1 | 0.165% | 0.495% |
5 | 1.088% | 2.92% |
10 | 3.025% | 7.448% |
15 | 5.777% | 13.209% |
20 | 9.879% | 21.994% |
Relationships between endpoints
↥Index endpoint: K11_CHOLANGI – Cholangitis (primary sclerosing, PSC)
GWS hits: 1